India Real Time Pcr, Digital Pcr, And End Point Pcr Market Size & Outlook
The real time pcr, digital pcr, and end point pcr market in India is expected to reach a projected revenue of US$ 177.2 million by 2030. A compound annual growth rate of -8.9% is expected of India real time pcr, digital pcr, and end point pcr market from 2024 to 2030.
Clinical Diagnostics
In Vitro Diagnostics
Real Time PCR, Digital PCR, And End Point PCR Market Outlook
India real time pcr, digital pcr, and end point pcr market highlights
The India real time pcr, digital pcr, and end point pcr market generated a revenue of USD 340.7 million in 2023 and is expected to reach USD 177.2 million by 2030.
The India market is expected to grow at a CAGR of -8.9% from 2024 to 2030.
In terms of segment, quantitative was the largest revenue generating technology in 2023.
Digital is the most lucrative technology segment registering the fastest growth during the forecast period.
Real time pcr, digital pcr, and end point pcr market data book summary
Market revenue in 2023
USD 340.7 million
Market revenue in 2030
USD 177.2 million
Growth rate
-8.9% (CAGR from 2023 to 2030)
Largest segment
Quantitative
Fastest growing segment
Digital
Historical data
2018 - 2022
Base year
2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Quantitative, Digital, End-point
Key market players worldwide
Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation
Other key industry trends
In terms of revenue, India accounted for 4.4% of the global real time pcr, digital pcr, and end point pcr market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China real time pcr, digital pcr, and end point pcr market is projected to lead the regional market in terms of revenue in 2030.
Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 479.9 million by 2030.
Cardiovascular diseases are the primary cause of mortality in India. According to a Global Burden of Disease study published in 2022, India has a higher cardiovascular disease death rate than the global average.
Around 349 per 100,000 people are diagnosed with some form of cardiovascular disorder in India. Moreover, the prevalence of infectious diseases is expected to increase the demand for PCR tests.
Rapid economic development in the nation has dramatically increased purchasing capacity, propelling the demand in the market. In February 2023, the Ministry of Health and Family Welfare’s decision to ease guidelines for international passengers, stating that individuals from certain countries would not require COVID-19 tests upon arrival in India, marked a significant shift in travel protocols.
India Real Time PCR, Digital PCR, And End Point PCR Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Real Time PCR, Digital PCR, And End Point PCR Market Outlook will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 90.08% in 2023.
Horizon Databook has segmented the India real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
Cardiovascular diseases are the primary cause of mortality in India. According to a Global Burden of Disease study published in 2022, India has a higher cardiovascular disease death rate than the global average.
Around 349 per 100,000 people are diagnosed with some form of cardiovascular disorder in India. Moreover, the prevalence of infectious diseases is expected to increase the demand for PCR tests.
Rapid economic development in the nation has dramatically increased purchasing capacity, propelling the demand in the market. In February 2023, the Ministry of Health and Family Welfare’s decision to ease guidelines for international passengers, stating that individuals from certain countries would not require COVID-19 tests upon arrival in India, marked a significant shift in travel protocols.
India Real Time Pcr, Digital Pcr, And End Point Pcr Market Technology Outlook (Revenue, USD Million , 2018-2030)
Quantitative
Digital
End-point
India Real Time Pcr, Digital Pcr, And End Point Pcr Market Product Outlook (Revenue, USD Million , 2018-2030)
Consumables & Reagents
Instruments
Software & Services
India Real Time Pcr, Digital Pcr, And End Point Pcr Market Application Outlook (Revenue, USD Million , 2018-2030)
Clinical
Research
Forensic
Reasons to subscribe to Real Time PCR, Digital PCR, And End Point PCR Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Real Time PCR, Digital PCR, And End Point PCR Market Outlook databook
Our clientele includes a mix of Real Time PCR, Digital PCR, And End Point PCR Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Real Time PCR, Digital PCR, And End Point PCR Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Real Time PCR, Digital PCR, And End Point PCR Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
India Real Time Pcr, Digital Pcr, And End Point Pcr Market, 2018-2030 (US$M)